Abbott, other formula makers face FTC investigation for collusion: WSJ

Published On 2023-05-24 07:00 GMT   |   Update On 2023-05-24 10:28 GMT
Advertisement

US: The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.

The FTC is looking into whether Abbott Laboratories and other formula manufacturers have "engaged in collusion or coordination with any other market participant regarding the bidding", the WSJ report said, citing documents posted to FTC's website.

Advertisement

The Journal added that the antitrust agency is also investigating whether company coordination affected sales more broadly, outside of the Women, Infants and Children (WIC) formula-supply program.

The FTC has sought information from Nestle, which makes the Good Start line of infant formulas, a company spokeswoman told the Journal, adding that the Swiss manufacturer has responded to the FTC.

FTC, Abbott, and Nestle did not immediately respond to Reuters requests for comment.

In February, Abbott said it received a civil investigative demand from the FTC related to a probe of the companies participating in bids for WIC formula contracts.

Read also: Abbott gets FTC notice for information on infant formula products



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News